$0.99
+0.00 (+0.35%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,895.1% upside
Low Target
$18.07
Average Target
$19.72
High Target
$32.84
Current Price
$0.99
Current
$0.99
$0.99
Target
$19.72
$19.72
$18.07
$19.72 avg
$32.84
Scenario Analysis
Bear Case
$18.07
1,728.2%
Low target
Base Case
$19.72
+1,895.1%
Avg target
Bull Case
$32.84
+3,222.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$7.54
-86.9% from high
52-Week Low
$0.95
+4.5% from low
Target vs 52W High
$19.72
+161.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |